Historique
Bulletin de Périodique
Substance Use and Misuse , Vol.48, n°11 - 2013 - Stakeholders in opioid substitution treatment policy: Similarities and differences in six European countries
Auteur(s) :
F. BECCARIA, Éditeur scientifique ;
S. EINSTEIN, Éditeur scientifique ;
B. THOM, Éditeur scientifique
Paru le :
01/09/2013
Article en page(s) :
933-1080
Sous-type de document :
N° spécial de revue / Special issue of a journal
Langue(s) :
Anglais
Thésaurus mots-clés
TRAITEMENT DE MAINTENANCE
;
POLITIQUE
;
ABSTINENCE
Thésaurus géographique
EUROPE
;
ROYAUME-UNI
;
DANEMARK
;
ITALIE
;
AUTRICHE
;
POLOGNE
;
FINLANDE
Note générale :
Commentary: Care of people with substance use disorders - A commentary on a series of papers on opioid substitution treatment published in Substance Use and Misuse. ANDERSON P. Drugs: Education, Prevention, and Policy, 2013;20(6): p. 488-490.
Note de contenu :
CONTENTS:
- Stakeholders in opioid substitution treatment policy: similarities and differences in six European countries. Thom B., Duke K., Frank V.A., Bjerge B., p. 933-942.
- Stakeholders' role in contemporary "substitute drug" prescribing policies in Italy. Beccaria F., Rolando S., p. 943-953.
- Behind the scenes: the justifications for opioid maintenance treatment in Finland. Perala R., Hellman M., Leppo A., p. 954-965.
- Substitution Treatment in the Era of "Recovery": An Analysis of Stakeholder Roles and Policy Windows in Britain. Duke K., Herring R., Thickett A., Thom B., p. 966-976.
- Walking through mud; history of the Polish methadone maintenance treatment from its stakeholders' perspective. Moskalewicz J., Welbel M., p. 977-996.
- Shifts in opioid substitution treatment policy in Denmark from 2000-2011. Frank V.A., Bjerge B., Houborg E., p. 997-1009.
- Deviance or innovation? Recent changes of drug substitution treatment policy in Austria. Eisenbach-Stangl I., p. 1010-1021.
- Puzzling about opiate substitution therapy: A synopsis and commentary. Adrian M., p. 1022-1023.
- Piecing together stakeholder puzzles-puzzling about (Opioid Substitute Treatment-OST) stakeholders and their pieces: A rambling point-of-view. Einstein S., p. 1024-1058.
- Commentary on "Substitution treatment in the era of 'recovery': An analysis of stakeholder roles and policy windows in Britain". Neale J., p. 1059-1060.
- Commentary on Irmgard Eisenbach-Stangl, "Deviance or innovation? Recent changes of drug substitution treatment policy in Austria". Malinowska-Sempruch K., p. 1061-1062.
- Commentary on Jacek Moskalewicz and Marta Welbel, "Walking through mud; History of the Polish methadone maintenance treatment from its stakeholders' perspective". Malinowska-Sempruch K., p. 1063-1064.
- Commentary on "Stakeholders' role in contemporary 'substitute drug' prescribing policies in Italy" by Franca Beccaria and Sara Rolando. Minutillo A., Zuccaro P., p. 1065-1066.
- Tracing the justifications of opioid maintenance treatment in Finland. Selin J., p. 1067-1068.
- Commentary on Vibeke Asmussen Frank, Bagga Bjerge, and Esben Houborg: Medicalization can be beneficial, but is no guarantee for user influence. Stenius K., p. 1069-1070.
- Stakeholders in opioid substitution treatment policy: similarities and differences in six European countries. Thom B., Duke K., Frank V.A., Bjerge B., p. 933-942.
- Stakeholders' role in contemporary "substitute drug" prescribing policies in Italy. Beccaria F., Rolando S., p. 943-953.
- Behind the scenes: the justifications for opioid maintenance treatment in Finland. Perala R., Hellman M., Leppo A., p. 954-965.
- Substitution Treatment in the Era of "Recovery": An Analysis of Stakeholder Roles and Policy Windows in Britain. Duke K., Herring R., Thickett A., Thom B., p. 966-976.
- Walking through mud; history of the Polish methadone maintenance treatment from its stakeholders' perspective. Moskalewicz J., Welbel M., p. 977-996.
- Shifts in opioid substitution treatment policy in Denmark from 2000-2011. Frank V.A., Bjerge B., Houborg E., p. 997-1009.
- Deviance or innovation? Recent changes of drug substitution treatment policy in Austria. Eisenbach-Stangl I., p. 1010-1021.
- Puzzling about opiate substitution therapy: A synopsis and commentary. Adrian M., p. 1022-1023.
- Piecing together stakeholder puzzles-puzzling about (Opioid Substitute Treatment-OST) stakeholders and their pieces: A rambling point-of-view. Einstein S., p. 1024-1058.
- Commentary on "Substitution treatment in the era of 'recovery': An analysis of stakeholder roles and policy windows in Britain". Neale J., p. 1059-1060.
- Commentary on Irmgard Eisenbach-Stangl, "Deviance or innovation? Recent changes of drug substitution treatment policy in Austria". Malinowska-Sempruch K., p. 1061-1062.
- Commentary on Jacek Moskalewicz and Marta Welbel, "Walking through mud; History of the Polish methadone maintenance treatment from its stakeholders' perspective". Malinowska-Sempruch K., p. 1063-1064.
- Commentary on "Stakeholders' role in contemporary 'substitute drug' prescribing policies in Italy" by Franca Beccaria and Sara Rolando. Minutillo A., Zuccaro P., p. 1065-1066.
- Tracing the justifications of opioid maintenance treatment in Finland. Selin J., p. 1067-1068.
- Commentary on Vibeke Asmussen Frank, Bagga Bjerge, and Esben Houborg: Medicalization can be beneficial, but is no guarantee for user influence. Stenius K., p. 1069-1070.
Résumé :
The papers presented in this special issue derive from the ALICE RAP project (Addictions and Lifestyles in Contemporary Europe: Reframing Addictions Project), financed by the EU FP7 Framework program. ALICE RAP is a multidisciplinary research program that employs a wide range of theoretical and methodological approaches to examine the "addictions" in contemporary European countries in relation to governance, public policy, and responses (http://www.alicerap.eu/). [Extract of the introduction]
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |